Heart BMJ

DECEMBER 15, 2023

Learning objectives Understand which patients with heart failure should be considered for a primary prevention implantable cardioverter defibrillator (ICD). Introduction Four decades ago, Mirowski et al reported on the first three humans treated with an automatic implantable defibrillator.

Defibrillator 40

Defibrillator Heart Failure Article 40

American College of Cardiology

JANUARY 20, 2024

The RAFT trial sought to study the safety and efficacy of CRT-D, as compared with ICD alone in patients with mild to moderate symptoms (NYHA class II/III), LV systolic dysfunction (ejection fraction [EF] ≤30%), and wide QRS complex.

Heart Failure 59

Heart Failure Defibrillator Article 59

HeartRhythm

APRIL 30, 2024

Ventricular arrhythmias and heart failure are common presentations of cardiac sarcoidosis (CS). Guidelines support implantable cardioverter-defibrillator (ICD) for many CS patients with reduced ejection fraction, but arrhythmic outcomes are poorly understood.

Defibrillator 40

Defibrillator Heart Failure Arrhythmia Outcomes 40

HeartRhythm

MAY 11, 2024

Trajectories of mortality after primary implantable cardioverter-defibrillator (ICD) placement for older heart failure (HF) patients during or soon after acute hospitalization have not been assessed.

Defibrillator 40

Defibrillator Heart Failure Hospital 40

HeartRhythm

OCTOBER 6, 2024

To predict worsening heart failure hospitalizations (WHFHs), the HeartInsight multiparametric algorithm calculates a Heart Failure (HF) Score based on temporal trends of physiologic parameters obtained through automatic daily remote monitoring of implantable cardioverter-defibrillators (ICDs).

Heart Failure 40

Heart Failure Defibrillator Physiology Hospital 40

DAIC

MAY 17, 2024

Based on the Health Data Hub complete medico-administrative database and comprehensive datasets from Implicity's AI -based remote monitoring platform, the Implicity team trained and validated a machine learning algorithm that assesses the risk of future heart failure events, enabling physicians to intervene before a patient requires hospitalization.

Heart Failure 52

Heart Failure Pacemaker Hospital Defibrillator 52

American College of Cardiology

DECEMBER 11, 2024

The following are key points to remember from a state-of-the-art review on revisiting implantable cardioverter-defibrillator (ICD) therapy for primary prevention in patients with heart failure and reduced ejection fraction (HFrEF).

Defibrillator 75

Defibrillator Heart Failure Article 75

HeartRhythm

APRIL 30, 2024

Hospitalizations are common in patients with heart failure and are associated with high mortality, readmission, and economic burden. Detecting early signs of worsening heart failure allows early intervention and can reduce hospitalizations.

Heart Failure 40

Heart Failure Physiology Defibrillator Hospital 40

European Journal of Heart Failure

MARCH 19, 2025

Abstract Patients presenting with or alerting emergency networks due to acute heart failure (AHF) form a diverse group with a plethora of symptoms, risks, comorbidities, and aetiologies. Scientific guidelines provide clear recommendations for the management of arrhythmias in chronic heart failure patients.

Heart Failure 40

Heart Failure Cardiogenic Shock Arrhythmia Heart Rhythm 40

European Journal of Heart Failure

JANUARY 9, 2025

Heart failure (HF) duration and guideline-recommended therapy implementation. Additionally, 18% received cardiac resynchronization therapy/implantable cardioverter-defibrillator >12months after diagnosis. The extent to which this occurs in new-onset HFrEF is unclear.

Heart Failure 40

Heart Failure Defibrillator Research Article 40

HeartRhythm

OCTOBER 17, 2024

The HeartLogic algorithm (Boston Scientific, St Paul, MN) integrates data from implantable cardioverter-defibrillator (ICD) sensors to predict heart failure (HF) decompensation: first (S1) and third (S3) heart sounds, intrathoracic impedance, respiration rate, ratio of respiration rate to tidal volume (RSBI), and night heart rate.

Heart Failure 40

Heart Failure Defibrillator 40

HeartRhythm

APRIL 30, 2024

We have previously shown an association between metabolic syndrome (MS) and heart failure (HF) outcomes in patients with implanted defibrillators (ICD) and cardiac resynchronization therapy (CRT-D). However, the role of MS and diabetes in predicting HF outcomes was not assessed in non-obese patients.

Heart Failure 40

Heart Failure Obesity Diabetes Outcomes 40

HeartRhythm

NOVEMBER 21, 2024

There are limited data on clinical and arrhythmic outcomes following a first ventricular tachyarrhythmia (VTA) in heart failure (HF) patients who receive a primary prevention implantable cardioverter-defibrillator (ICD).

Defibrillator 40

Defibrillator Heart Failure Outcomes 40

HeartRhythm

APRIL 30, 2024

However, the prevalence of frequent PVCs among patients with heart failure with reduced ejection fraction (HFrEF) and the impact of cardiac resynchronization therapy (CRT) on PVC burden is unknown. Frequent premature ventricular complexes are associated with the development of left ventricular dysfunction.

Heart Failure 40

Heart Failure Defibrillator 40

American College of Cardiology

MARCH 29, 2024

Can the baseline frailty status of patients with heart failure (HF) be used to predict who will benefit the most from placement of an implantable cardioverter-defibrillator (ICD) for primary prevention?

Defibrillator 65

Defibrillator Heart Failure Article 65

HeartRhythm

APRIL 30, 2024

In part due to advances in guideline-directed medical therapy (GDMT) and availability of implantable cardioverter-defibrillators (ICDs), cardiac arrest (CA) rates among patients with heart Failure (HF) decreased in the early 2000s. Relatively little is known about trends in CA associated with HF over the past decade.

Cardiac Arrest 40

Cardiac Arrest Heart Failure Defibrillator 40

Open Heart

NOVEMBER 28, 2022

Background Remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) is now the standard of care, but whether the demonstrated benefits of RM translate into improvements in heart failure (HF) management is controversial. This systematic review addresses the role of RM in patients with HF with a CIED.

Heart Failure 52

Heart Failure Defibrillator Article Hospital 52

HeartRhythm

OCTOBER 8, 2024

Amongst patients with left ventricular systolic dysfunction and prolonged QRS duration, cardiac resynchronization therapy (CRT) can improve cardiac electromechanical synchrony, and prevent adverse clinical outcomes.

Heart Failure 45

Heart Failure Defibrillator Outcomes 45

Dr. Smith's ECG Blog

APRIL 2, 2024

He was defibrillated, but they also noticed that he was being internally defibrillated and then found that he had an implantable ICD. He was unidentified and there were no records available After 7 shocks, he was successfully defibrillated and brought to the ED. There was no bystander CPR.

Tachycardia 132

Tachycardia Pacemaker Cardiac Arrest Cardiomyopathy 132

HeartRhythm

JULY 17, 2024

Left ventricular assist device (LVAD) implantation is an established therapy for patients with end-stage heart failure, with the HeartMate 3 (HM3; Abbott, Plymouth, MN) system currently representing the most widely employed device.1

Defibrillator 40

Defibrillator Heart Failure 40

Dr. Smith's ECG Blog

JANUARY 2, 2025

Permanent pacer placement Later, a biventricular pacer was placed for " Cardiac Resynchronization Therapy (CRT) " (This is indicated for patients with LBBB and QRS duration > 130 ms and heart failure and vastly improves heart failure). See Dr. Karim's further thoughts on this below. No wall motion abnormality.

Tachycardia 116

Tachycardia Cardiomyopathy Blog Bradycardia 116

HeartRhythm

APRIL 30, 2024

Cardiac resynchronization (CRT) with biventricular pacing (BVP) is recognized as an option to reduce mortality in patients with heart failure with reduced ejection fraction (HFrEF). Left bundle branch area pacing (LBBAP) is an emerging role in achieving resynchronization in HFrEF and is thought to be a safe alternative to BVP.

Heart Failure 40

Heart Failure Arrhythmia Atrial Fibrillation Defibrillator 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 27, 2023

Abstract Continuous flow left ventricular assist devices (CF-LVADs) have been shown to reduce mortality and morbidity in patients with advanced heart failure with reduced ejection fraction.

Defibrillator 40

Defibrillator Arrhythmia Best Practices Quality of Life 40

All About Cardiovascular System and Disorders

MAY 1, 2024

CRT is used in heart failure with reduced ejection fraction. According to the Universal Definition and Classification of Heart Failure, heart failure with reduced ejection fraction has left ventricular ejection fraction of 40% or less. CRT stands for cardiac resynchronization therapy.

Heart Failure 52

Heart Failure Arrhythmia Pacemaker Defibrillator 52

HeartRhythm

JANUARY 2, 2024

In patients with heart failure (HF) undergoing left bundle branch area pacing (LBBAP) for cardiac resynchronization therapy (CRT) without a defibrillator (e.g., elderly patients or non-ischemic cardiomyopathy, in whom the use of a defibrillator has been questioned),1 the use of a right ventricular (RV) lead may not be necessary.

Reimbursement 40

Reimbursement Defibrillator Pacemaker Heart Failure 40

The American Journal of Cardiology

DECEMBER 13, 2023

Publication date: 15 January 2024 Source: The American Journal of Cardiology, Volume 211 Author(s): Moshe Rav-Acha, Orli Wube, Oholi Tovia Brodie, Yoav Michowitz, Michael Ilan, Tal Ovdat, Robert Klempfner, Mahmud Suleiman, Ilan Goldenberg, Michael Glikson

Heart Failure 40

Heart Failure Defibrillator 40

Open Heart

MARCH 16, 2023

Introduction Several studies have demonstrated that combining left ventricular ejection fraction and New York Heart Association functional class is insufficient for predicting risk of appropriate implantable cardioverter-defibrillator (ICD) shock in primary prevention candidates.

Defibrillator 40

Defibrillator Heart Failure Outcomes 40

Journal of Cardiothoracic Surgery

JUNE 21, 2024

The clinical outcomes including mechanical ventilation time, intensive care unit stay time, hospital stay time, postoperative stroke, postoperative new-onset atrial fibrillation, postoperative heart failure requiring intra-aortic balloon pump mechanical circulation support, and in-hospital mortality of both are comparable.

Atrial Fibrillation 52

Atrial Fibrillation Defibrillator Heart Failure Aortic 52

European Journal of Heart Failure

NOVEMBER 9, 2023

Abstract Aim Cardiac resynchronization therapy (CRT) is a cornerstone in the management of chronic heart failure in patients with a broad or paced QRS. The primary composite endpoint included all-cause mortality, heart transplantation, or ventricular assist device implantation. ml/min/1.73 m ml/min/1.73 m 76.5], p  < 0.001).

Outcomes 40

Outcomes Heart Failure Heart Transplant Transplant 40

Dr. Smith's ECG Blog

OCTOBER 18, 2023

She spontaneously converted (Defibrillation was not performed). Most such rhythms in the setting of ischemia are VF and will not convert without defibrillation. NT-pro-BNP peaked at 4831, consistent with heart failure. The patient was given chest compressions while waiting for the cardiac arrest team to arrive.

Cardiac Arrest 122

Cardiac Arrest Tachycardia Cardiomyopathy Bradycardia 122

Cardiometabolic Health Congress

AUGUST 30, 2024

Arrhythmias : A leadless pacemaker-defibrillator system provides antitachycardia pacing for ventricular tachycardia in patients with subcutaneous ICDs. Coronary Heart Disease : Initiate beta-blockers in patients with acute MI and normal LVEF unless contraindicated or if they have heart failure.

Cardiac Rehabilitation 52

Cardiac Rehabilitation Heart Failure Quality of Life Aortic 52

All About Cardiovascular System and Disorders

MARCH 20, 2024

But while compressing here in a patient with heart failure, it can elicit pain because there could be tender hepatomegaly in patients with heart failure. That occurs in right heart failure and constrictive pericarditis. Then, these are the important waves to be looked at in the jugular venous pulsation.

Tricuspid 52

Tricuspid Pericarditis VSD Heart Failure 52

Vector Remote

MAY 9, 2023

For cardiac clinics, that typically includes the following types of devices: Implantable Cardioverter Defibrillators (ICDs). These devices are implanted under the skin and can monitor the heart’s rhythm, delivering as-needed electrical shocks to correct abnormal heart rhythms.

Heart Rhythm 52

Heart Rhythm Technology Blood Pressure Defibrillator 52

EMS 12-Lead

MARCH 19, 2023

He denied any known medical history, specifically: coronary artery disease, hypertension, dyslipidemia, diabetes, heart failure, myocardial infarction, or any prior PCI/stent. Despite immediate chest compressions, and multiple rounds of defibrillation, he could not be resuscitated. Breath sounds were clear in all lung fields.

Myocardial Infarction 52

Myocardial Infarction STEMI Coronary Angiogram Coronary Artery Disease 52

Cardiology Update

JANUARY 22, 2024

The Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT; NCT00251251 ) demonstrated a greater 5-year mortality benefit for patients receiving cardiac-resynchronization therapy (CRT) compared to those receiving implantable cardioverter–defibrillators (ICDs). years, with a median of 13.9

Heart Failure 115

Heart Failure Defibrillator Heart Transplant Transplant 115

HeartRhythm

MARCH 28, 2025

The implantable cardioverter-defibrillator (ICD) remains one of the most effective therapies for preventing sudden cardiac death (SCD). Data supporting the role of primary prevention ICDs in patients with heart failure were generated by rigorous randomized controlled trials (RCTs).1

Defibrillator 40

Defibrillator Heart Failure Sudden Cardiac Death Technology 40

Dr. Smith's ECG Blog

MARCH 15, 2023

We examined the effect of ibutilide, a class III antiarrhythmic agent, on the energy requirement for atrial defibrillation and assessed the value of this agent in facilitating cardioversion in patients with atrial fibrillation that is resistant to conventional transthoracic cardioversion.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Arrhythmia Exercise 52